Innovent Biologics Inc (IVBIY)
19.48
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Innovent Biologics Shareholders Equity (Quarterly): 1.767B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.767B |
| June 30, 2023 | 1.487B |
| June 30, 2023 | 1.487B |
| December 31, 2022 | 1.555B |
| June 30, 2022 | 1.431B |
| June 30, 2022 | 1.431B |
| December 31, 2021 | 1.621B |
| June 30, 2021 | 1.841B |
| June 30, 2021 | 1.841B |
| December 31, 2020 | 1.344B |
| Date | Value |
|---|---|
| June 30, 2020 | 903.18M |
| June 30, 2020 | 903.18M |
| December 31, 2019 | 679.76M |
| June 30, 2019 | 512.34M |
| June 30, 2019 | 512.34M |
| December 31, 2018 | 609.74M |
| June 30, 2018 | -237.45M |
| June 30, 2018 | -237.45M |
| December 31, 2017 | -297.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
512.34M
Minimum
Jun 2019
1.841B
Maximum
Jun 2021
1.288B
Average
1.431B
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.709B |
| CASI Pharmaceuticals Inc | 24.16M |
| Zai Lab Ltd | 762.17M |
| Gracell Biotechnologies Inc (DELISTED) | 222.18M |
| Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.910B |
| Total Liabilities (Quarterly) | 1.143B |
| Debt to Equity Ratio | 0.2811 |
| Current Ratio | 3.000 |
| Net Debt Paydown Yield | -0.39% |